Wilbur Milhous, Ph.D.

Professor Came to USF: 2007
Contact Information: Office: CPH E-Mail: wmilhous@health.usf.edu Phone: (813) 974-2079 FAX: (813) 974-8506	Discipline: Tropical Public Health
	Specialization: Molecular Biology and Drug Development Microbiology Tropical Public Health
Degrees: B.S. Microbiology, Clemson University, 1972 Ph.D. Public Health, UNC Chapel Hill, 1983	Other Information: Milhous biosketch Milhous cv

Dr. Wilbur Kearse Milhous is newly appointed (July 9, 2007) as Associate Dean for Research at the USF College of Public Health , where he also serves as a Professor of Global Health and researcher with the USF Global Health Infectious Disease Research (GHIDR) program. In his role as Associate Dean for Research, Dr. Milhous leads a team of more than 100 public health researchers and general faculty members and oversees the college's multimillion dollar research and training centers. USF's College of Public Health was the first accredited school of public health in Florida. In 2006, the college was the recipient of more than $16 million in external funding alone, building its research base with awards for public health preparedness, bioterrorism surveillance, community-based marketing and community engagement. Under Dr. Milhous' leadership, the college is focused on key areas of research that include health disparities, maternal and child health, and global health.

While Dr. Milhous is new to USF, he brings 26 years of global health experience. Prior to joining the USF College of Public Health, Dr. Milhous served as Research Coordinator for the Military Infectious Disease Research Program and Chief Science Officer at the Walter Reed Army Institute of Research (WRAIR) in Maryland and the overseas labs in Thailand, Kenya, Peru, Ghana, and Australia. At WRAIR, the nation's oldest school of public health and preventive medicine and the largest biomedical research facility in the DoD, he directed translational research and became an internationally recognized leader in the field of malaria chemotherapy. He has made a name for himself in translational research with his ability to move drugs from the early stages of research into clinical trials in the field and regulatory approval by assembling and directing multidisciplinary research. While assigned to Brazil he directed clinical trials for Malarone-Malaria and Sitamoquine-Leishmaniasis and his integrated process team recently filed an IND intravenous artesunate and made it available for compassionate use at the CDC.

Dr. Milhous is a Fellow of the Academy and Diplomat of American Board of Medical Microbiology. With appointments in Preventive Medicine and Microbiology & Immunology at Uniformed Services University, he served as an instructor for medical students, graduate students, clinical pharmacology & infectious disease fellows. As a senior National Research Council advisor, he has a robust research and publication record (8 patents, 120 manuscripts & 12 book chapters). The majority of his publications have international authorship including recent drug resistance observations in Fogarty sponsored research in West Africa. He has served as PI, Co-PI or senior advisor of multiple research grant awards from the National Institutes of Allergy and Infectious Disease (NIAID), World Health Organization (WHO), and the Medicines for Malaria Venture (MMV).

Dr. Milhous is an advisory board member to numerous international organizations and his research awards include the Gorgas Medal for Distinguished Work in Preventive Medicine, the Ashford Medal for Distinguished Work in Tropical Medicine and two USA R&D Achievement Awards for novel therapeutics. He obtained his PhD from the University of North Carolina & received the Greenberg Award in a school-wide competition for doctoral research. Dr. Milhous began his public health career as a registered specialist in Public Health and Medical Microbiology at military hospitals in Louisiana and North Carolina, and underwent post graduate specialty training at National Institutes of Allergy and Infectious Disease (NIAID), Centers for Disease Control (CDC) and Duke University.